Press release
Ascites Treatment Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight
DelveInsight's "Ascites Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Ascites, historical and forecasted epidemiology as well as the Ascites market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Unlock detailed insights into the Ascites Market by downloading the comprehensive report from DelveInsight @ Ascites Treatment Market Size [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Ascites Market Report
* In September 2024:- Versantis AG- A Phase 2a, Open-label, Randomized, Controlled, Multi-Center Study to Assess the Efficacy, Safety and Tolerability of VS-01 on Top of Standard of Care (SOC), Compared to SOC Alone, in Adult Patients With Acute-on-Chronic Liver Failure (ACLF) Grades 1 and 2 and Ascites.
* It is estimated that the Ascites treatment market will experience significant changes during the forecast period of 2024-2034, owing to the launch of new therapies that are in clinical development.
* DelveInsight analysis indicates that in 2023, the US had approximately 153 thousand cases of Ascites due to Cirrhosis, accounting for the largest share in the 7MM.
* DelveInsight's analysis revealed that in Japan during 2023, there were 5,355 instances of Grade I ascites attributed to cirrhosis. Additionally, more severe cases of Grade II and III ascites were recorded at 24,394 cases each in the same year.
* The leading Ascites Companies such as Grifols Therapeutics LLC, Sanofi, Regeneron Pharmaceuticals, Sequana Medical N.V, Protgen Ltd, Healthgen Biotechnology Corp, Sichuan Clover Biopharmaceuticals Inc, Movetis, BioVie Inc., Ocelot Bio Inc, Novartis , and others.
* Promising Ascites Therapies such as Recombinant Human Serum Albumin, M701, paracentesis, OrsHSA, VS-01, Ambrisentan, Terlipressin, and others.
Gain a competitive edge in the Ascites Market by exploring our in-depth analysis. Visit our website to access the full report and make informed strategic decisions @ Ascites Treatment Drugs [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Ascites Epidemiology Segmentation in the 7MM
* Number of Ascites Cases by Malignancies
* Number of Ascites Cases due to Cirrhosis
* Severity-specific Cases of Ascites due to Cirrhosis
* Refractory Ascites Patients with Cirrhosis
Ascites Treatment Market Landscape
The treatment landscape of ascites due to cirrhosis include diuretics, paracentesis, insertion of a transjugular intrahepatic portosystemic shunt (TIPS), as well as managing complications to ascites such as spontaneous bacterial peritonitis (SBP). Mild and moderate ascites due to liver cirrhosis can be treated with dietary sodium restriction, treatment of the underlying disorder, fluid restriction, use of diuretics, and use of therapeutic paracentesis.
Discover key developments and opportunities in the Ascites Market. Click here to learn more from DelveInsight's latest report @ Ascites Market Size [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Ascites Drugs Market
The Ascites market for drugs targeting ascites is notably constrained. While certain treatments provide symptomatic relief, there is a significant lack of approved drugs addressing the condition's underlying causes. This scarcity of targeted treatments reflects a major challenge in effectively managing the diverse manifestations of ascites, indicating a substantial need for innovative solutions and advancements in drug development for more comprehensive care.
Ascites Emerging Drugs Profile
* OCE-205: Ocelot Bio
* BIV201 (terlipressin): Biovie
Download DelveInsight's Ascites Market report today and stay ahead in this rapidly evolving field. @ Ascites Clinical Trials [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Ascites Market Report
* Coverage- 7MM
* Ascites Companies- as Grifols Therapeutics LLC, Sanofi, Regeneron Pharmaceuticals, Sequana Medical N.V, Protgen Ltd, Healthgen Biotechnology Corp, Sichuan Clover Biopharmaceuticals Inc, Movetis, BioVie Inc., Ocelot Bio Inc, Novartis, and others.
* Ascites Therapies- Recombinant Human Serum Albumin, M701, paracentesis, OrsHSA, VS-01, Ambrisentan, Terlipressin, and others.
* Ascites Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
* Ascites Unmet Needs, KOL's views, Analyst's views, Ascites Market Access and Reimbursement
Download the report to understand which factors are driving Ascites Market Trends @ Ascites Market Trends [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Key Insights
2. Report Introduction
3. Executive Summary
4. Ascites Market Overview at a Glance
5 Key Events
6 Epidemiology and Market Forecast Methodology
7 Disease Background and Overview
8 Epidemiology and Patient Population
9 Patient Journey
10 Emerging Therapies
11 Ascites: Seven Major Market Analysis
12 Unmet Needs
13 SWOT Analysis
14 KOL Views
15 Market Access and Reimbursement
16 Appendix
17 DelveInsight Capabilities
18 Disclaimer
19 About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ascites-treatment-market-size-in-the-7mm-is-expected-to-grow-by-2034-estimates-delveinsight]
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ascites Treatment Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight here
News-ID: 3668128 • Views: …
More Releases from ABNewswire
Epidermolysis Bullosa Pipeline 2024: Clinical Trials Assessment, FDA Approvals, …
Epidermolysis Bullosa pipeline constitutes 20+ key companies continuously working towards developing 21+ Epidermolysis Bullosa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Epidermolysis Bullosa Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/epidermolysis-bullosa-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Epidermolysis Bullosa Market.
The Epidermolysis Bullosa Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products…
Non-Alcoholic Steatohepatitis Pipeline Insights 2024: Therapies, Clinical Trials …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Non-Alcoholic Steatohepatitis pipeline constitutes 80+ key companies continuously working towards developing 80+ Non-Alcoholic Steatohepatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Non-Alcoholic Steatohepatitis Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/non-alcoholic-steatohepatitis-nash-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Non-Alcoholic Steatohepatitis Market.
The Non-Alcoholic Steatohepatitis Pipeline report…
Hyperkalemia Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Clini …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hyperkalemia pipeline constitutes key companies continuously working towards developing Hyperkalemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Hyperkalemia Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/hyperkalemia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hyperkalemia Market.
The Hyperkalemia Pipeline report embraces in-depth commercial and clinical assessment of…
Hypoparathyroidism Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hypoparathyroidism pipeline constitutes 10+ key companies continuously working towards developing 10+ Hypoparathyroidism treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Hypoparathyroidism Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/hypoparathyroidism-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hypoparathyroidism Market.
The Hypoparathyroidism Pipeline report embraces in-depth commercial and clinical…
More Releases for Ascites
Ascites Market Size, Share, Trends, Analysis and Forecast 2027
The Global Ascites Market is poised to register a CAGR of over 4% during the forecast period 2020 to 2027.
Ascites are a condition in which excessive fluid accumulates in the abdominal cavity. Ascites are most commonly caused by liver cirrhosis. Portal hypertension is a sign of its presence. Ascites may also be caused by heart failure, kidney failure, cancer, and pancreatic infection. The malignant ascites associated with ovarian cancer play…
Global Ascites Needle Market Analysis by 2020-2025
Global Info Research offers a latest published report on Ascites Needle Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Ascites Needle Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/Global-Ascites-Needle_p510224.html
Market…
Malignant Ascites Treatment Market: Competitive Dynamics & Global Outlook 2025
Market Research Report Store offers a latest published report on Malignant Ascites Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
This report focuses on the key global Malignant Ascites Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure…
Global Ascites Market Healthcare Analysis 2018 to 2023
Global and Chinese Ascites Industry, 2018 Market Research Report:
The 'Global and Chinese Ascites Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Ascites industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ascites manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.…
Malignant Ascites Treatment Market Opportunity Analysis - 2026
Ascites is the condition characterized by formation of excessive fluid in the abdominal cavity, particularly in the peritoneal cavity. It causes when the body is unable to eliminate out fluids. When ascites is developed due to cancer, it is called as malignant peritoneal effusion or malignant ascites. Malignancies that are most commonly associated with malignant ascites are cancers of breast, liver, ovary, lungs, lymphoma, and colon. In ascites condition, lymph…
Ascites Treatment Market Set to Surge Significantly During 2025
Peritoneal cavity is the space between lining of abdominal organs and abdomen. Accumulation of fluid in peritoneal cavity is refereed as ascites. In some cases, the condition is also referred as portal hypertension. Low levels of proteins (albumin) and portal hypertension i.e. high pressure in blood vessels of the liver results in ascites. Only 30% to 40% of the people suffering from ascites survive for around five years.
Report Overview @…
